Reneo is a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic mitochondrial diseases with significant unmet medical needs.
Amzak Health Investors
New Enterprise Associates
Rock Springs Capital
San Diego, California, United States
Register and Claim Ownership